Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 121 to 128 of 128 entries
Sorted by: Best Match Show Resources per page
Specific Macronutrients Exert Unique Influences on the Adipose-Liver Axis to Promote Hepatic Steatosis in Mice.

Cellular and molecular gastroenterology and hepatology

Duwaerts CC, Amin AM, Siao K, Her C, Fitch M, Beysen C, Turner SM, Goodsell A, Baron JL, Grenert JP, Cho SJ, Maher JJ.
PMID: 28649594
Cell Mol Gastroenterol Hepatol. 2017 Apr 22;4(2):223-236. doi: 10.1016/j.jcmgh.2017.04.004. eCollection 2017 Sep.

BACKGROUND & AIMS: The factors that distinguish metabolically healthy obesity from metabolically unhealthy obesity are not well understood. Diet has been implicated as a determinant of the unhealthy obesity phenotype, but which aspects of the diet induce dysmetabolism are...

Cite
Duwaerts CC, Amin AM, Siao K, et al. Specific Macronutrients Exert Unique Influences on the Adipose-Liver Axis to Promote Hepatic Steatosis in Mice. Cell Mol Gastroenterol Hepatol. 2017;4(2):223-236doi: 10.1016/j.jcmgh.2017.04.004.
Duwaerts, C. C., Amin, A. M., Siao, K., Her, C., Fitch, M., Beysen, C., Turner, S. M., Goodsell, A., Baron, J. L., Grenert, J. P., Cho, S. J., & Maher, J. J. (2017). Specific Macronutrients Exert Unique Influences on the Adipose-Liver Axis to Promote Hepatic Steatosis in Mice. Cellular and molecular gastroenterology and hepatology, 4(2), 223-236. https://doi.org/10.1016/j.jcmgh.2017.04.004
Duwaerts, Caroline C, et al. "Specific Macronutrients Exert Unique Influences on the Adipose-Liver Axis to Promote Hepatic Steatosis in Mice." Cellular and molecular gastroenterology and hepatology vol. 4,2 (2017): 223-236. doi: https://doi.org/10.1016/j.jcmgh.2017.04.004
Duwaerts CC, Amin AM, Siao K, Her C, Fitch M, Beysen C, Turner SM, Goodsell A, Baron JL, Grenert JP, Cho SJ, Maher JJ. Specific Macronutrients Exert Unique Influences on the Adipose-Liver Axis to Promote Hepatic Steatosis in Mice. Cell Mol Gastroenterol Hepatol. 2017 Apr 22;4(2):223-236. doi: 10.1016/j.jcmgh.2017.04.004. eCollection 2017 Sep. PMID: 28649594; PMCID: PMC5472193.
Copy Download .nbib Format: NLM
Severe dehydration among cholera patients in Yemen: A cohort profile.

Germs

Alassar MM, Adegboye OA, Emeto TI, Rahman KM, Mashood LO, Elfaki FA.
PMID: 33489949
Germs. 2020 Dec 28;10(4):338-345. doi: 10.18683/germs.2020.1226. eCollection 2020 Dec.

INTRODUCTION: Introduction Cholera, an acute diarrheal illness caused by ingestion of food or water contaminated with METHODS: This study aimed to describe the characteristics of a cohort of inpatients with cholera in two main hospitals in Taiz and Sana'a,...

Cite
Alassar MM, Adegboye OA, Emeto TI, et al. Severe dehydration among cholera patients in Yemen: A cohort profile. Germs. 2020;10(4):338-345doi: 10.18683/germs.2020.1226.
Alassar, M. M., Adegboye, O. A., Emeto, T. I., Rahman, K. M., Mashood, L. O., & Elfaki, F. A. (2020). Severe dehydration among cholera patients in Yemen: A cohort profile. Germs, 10(4), 338-345. https://doi.org/10.18683/germs.2020.1226
Alassar, Mohammed M, et al. "Severe dehydration among cholera patients in Yemen: A cohort profile." Germs vol. 10,4 (2020): 338-345. doi: https://doi.org/10.18683/germs.2020.1226
Alassar MM, Adegboye OA, Emeto TI, Rahman KM, Mashood LO, Elfaki FA. Severe dehydration among cholera patients in Yemen: A cohort profile. Germs. 2020 Dec 28;10(4):338-345. doi: 10.18683/germs.2020.1226. eCollection 2020 Dec. PMID: 33489949; PMCID: PMC7811862.
Copy Download .nbib Format: NLM
Hypoplastic Coronary Artery Disease Presenting with Ventricular Fibrillation Cardiac Arrest.

European journal of case reports in internal medicine

Guo A, Bakhshi H, O'Hara J, Genovese L, Fein A, Maghsoudi A, Sandesara C.
PMID: 34527617
Eur J Case Rep Intern Med. 2021 Aug 02;8(8):002736. doi: 10.12890/2021_002736. eCollection 2021.

Hypoplastic coronary artery disease is a rare congenital anomaly that may present with ischaemic heart disease, heart failure or sudden cardiac death (SCD). We describe a case of cardiac arrest in a healthy young man. Work-up revealed a hypoplastic...

Cite
Guo A, Bakhshi H, O'Hara J, et al. Hypoplastic Coronary Artery Disease Presenting with Ventricular Fibrillation Cardiac Arrest. Eur J Case Rep Intern Med. 2021;8(8):002736doi: 10.12890/2021_002736.
Guo, A., Bakhshi, H., O'Hara, J., Genovese, L., Fein, A., Maghsoudi, A., & Sandesara, C. (2021). Hypoplastic Coronary Artery Disease Presenting with Ventricular Fibrillation Cardiac Arrest. European journal of case reports in internal medicine, 8(8), 002736. https://doi.org/10.12890/2021_002736
Guo, Abra, et al. "Hypoplastic Coronary Artery Disease Presenting with Ventricular Fibrillation Cardiac Arrest." European journal of case reports in internal medicine vol. 8,8 (2021): 002736. doi: https://doi.org/10.12890/2021_002736
Guo A, Bakhshi H, O'Hara J, Genovese L, Fein A, Maghsoudi A, Sandesara C. Hypoplastic Coronary Artery Disease Presenting with Ventricular Fibrillation Cardiac Arrest. Eur J Case Rep Intern Med. 2021 Aug 02;8(8):002736. doi: 10.12890/2021_002736. eCollection 2021. PMID: 34527617; PMCID: PMC8436844.
Copy Download .nbib Format: NLM
[Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Fedin AI, Zakharov VV, Tanashyan MM, Chukanova EI, Madzhidova EN, Shchepankevich LA, Ostroumova OD.
PMID: 34932280
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(11):7-16. doi: 10.17116/jnevro20211211117.

OBJECTIVE: To assess the efficacy and safety of sequential therapy with Mexidol solution for intravenous and intramuscular administration, 50 mg/ml and Mexidol FORTE 250 film-coated tablets, 250 mg in patients with chronic brain ischemia (CBI).MATERIAL AND METHODS: An international...

Cite
Fedin AI, Zakharov VV, Tanashyan MM, et al. Rezul'taty mezhdunarodnogo mnogotsentrovogo randomizirovannogo dvoinogo slepogo platsebo-kontroliruemogo issledovaniya otsenki effektivnosti i bezopasnosti posledovatel'noi terapii patsientov s khronicheskoi ishemiei mozga preparatami Meksidol i Meksidol FORTE 250 (issledovanie MEMO). [Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)]. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(11):7-16doi: 10.17116/jnevro20211211117.
Fedin, A. I., Zakharov, V. V., Tanashyan, M. M., Chukanova, E. I., Madzhidova, E. N., Shchepankevich, L. A., & Ostroumova, O. D. (2021). Rezul'taty mezhdunarodnogo mnogotsentrovogo randomizirovannogo dvoinogo slepogo platsebo-kontroliruemogo issledovaniya otsenki effektivnosti i bezopasnosti posledovatel'noi terapii patsientov s khronicheskoi ishemiei mozga preparatami Meksidol i Meksidol FORTE 250 (issledovanie MEMO). [Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 121(11), 7-16. https://doi.org/10.17116/jnevro20211211117
Fedin, A I, et al. "Rezul'taty mezhdunarodnogo mnogotsentrovogo randomizirovannogo dvoinogo slepogo platsebo-kontroliruemogo issledovaniya otsenki effektivnosti i bezopasnosti posledovatel'noi terapii patsientov s khronicheskoi ishemiei mozga preparatami Meksidol i Meksidol FORTE 250 (issledovanie MEMO)." [Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol. 121,11 (2021): 7-16. doi: https://doi.org/10.17116/jnevro20211211117
Fedin AI, Zakharov VV, Tanashyan MM, Chukanova EI, Madzhidova EN, Shchepankevich LA, Ostroumova OD. Rezul'taty mezhdunarodnogo mnogotsentrovogo randomizirovannogo dvoinogo slepogo platsebo-kontroliruemogo issledovaniya otsenki effektivnosti i bezopasnosti posledovatel'noi terapii patsientov s khronicheskoi ishemiei mozga preparatami Meksidol i Meksidol FORTE 250 (issledovanie MEMO). [Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)]. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(11):7-16. doi: 10.17116/jnevro20211211117. Russian. PMID: 34932280.
Copy Download .nbib Format: NLM
Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study.

Journal of pharmaceutical sciences

Devinsky O, Kraft K, Rusch L, Fein M, Leone-Bay A.
PMID: 34400185
J Pharm Sci. 2021 Dec;110(12):3946-3952. doi: 10.1016/j.xphs.2021.08.012. Epub 2021 Aug 13.

Oral cannabidiol (CBD) is approved by the Food and Drug Administration (FDA) to treat patients with Dravet and Lennox-Gastaut syndromes and tuberous sclerosis complex. The therapeutic potential of oral CBD formulations is limited by extensive first-pass hepatic metabolism. Following...

Cite
Devinsky O, Kraft K, Rusch L, et al. Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study. J Pharm Sci. 2021;110(12):3946-3952doi: 10.1016/j.xphs.2021.08.012.
Devinsky, O., Kraft, K., Rusch, L., Fein, M., & Leone-Bay, A. (2021). Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study. Journal of pharmaceutical sciences, 110(12), 3946-3952. https://doi.org/10.1016/j.xphs.2021.08.012
Devinsky, Orrin, et al. "Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study." Journal of pharmaceutical sciences vol. 110,12 (2021): 3946-3952. doi: https://doi.org/10.1016/j.xphs.2021.08.012
Devinsky O, Kraft K, Rusch L, Fein M, Leone-Bay A. Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study. J Pharm Sci. 2021 Dec;110(12):3946-3952. doi: 10.1016/j.xphs.2021.08.012. Epub 2021 Aug 13. PMID: 34400185.
Copy Download .nbib Format: NLM
Complex Interaction as Emergent Behaviour: Simulating Mid-Air Virtual Keyboard Typing using Reinforcement Learning.

IEEE transactions on visualization and computer graphics

Hetzel L, Dudley J, Feit AM, Kristensson PO.
PMID: 34449380
IEEE Trans Vis Comput Graph. 2021 Nov;27(11):4140-4149. doi: 10.1109/TVCG.2021.3106494. Epub 2021 Oct 27.

Accurately modelling user behaviour has the potential to significantly improve the quality of human-computer interaction. Traditionally, these models are carefully hand-crafted to approximate specific aspects of well-documented user behaviour. This limits their availability in virtual and augmented reality where...

Cite
Hetzel L, Dudley J, Feit AM, et al. Complex Interaction as Emergent Behaviour: Simulating Mid-Air Virtual Keyboard Typing using Reinforcement Learning. IEEE Trans Vis Comput Graph. 2021;27(11):4140-4149doi: 10.1109/TVCG.2021.3106494.
Hetzel, L., Dudley, J., Feit, A. M., & Kristensson, P. O. (2021). Complex Interaction as Emergent Behaviour: Simulating Mid-Air Virtual Keyboard Typing using Reinforcement Learning. IEEE transactions on visualization and computer graphics, 27(11), 4140-4149. https://doi.org/10.1109/TVCG.2021.3106494
Hetzel, Lorenz, et al. "Complex Interaction as Emergent Behaviour: Simulating Mid-Air Virtual Keyboard Typing using Reinforcement Learning." IEEE transactions on visualization and computer graphics vol. 27,11 (2021): 4140-4149. doi: https://doi.org/10.1109/TVCG.2021.3106494
Hetzel L, Dudley J, Feit AM, Kristensson PO. Complex Interaction as Emergent Behaviour: Simulating Mid-Air Virtual Keyboard Typing using Reinforcement Learning. IEEE Trans Vis Comput Graph. 2021 Nov;27(11):4140-4149. doi: 10.1109/TVCG.2021.3106494. Epub 2021 Oct 27. PMID: 34449380.
Copy Download .nbib Format: NLM
Sustaining the Clinical and Translational Research Workforce: Training and Empowering the Next Generation of Investigators.

Fair AM, Yin HL, Gabrilove J, Jackson R, Sweeney C, Toto R.
UIID-AD: 3560
2015;861-5. doi: 10.1097/acm.0000000000000758.

There is mounting concern that clinician-scientists are a vanishing species and that the pipeline for clinical and translational research (CTR) investigators is in jeopardy. For the majority of current junior CTR investigators, the career path involves first obtaining a...

Cite
Fair AM, Yin HL, Gabrilove J, et al. Sustaining the Clinical and Translational Research Workforce: Training and Empowering the Next Generation of Investigators. 2015;861-5doi: 10.1097/acm.0000000000000758.
Fair, A. M., Yin, H. L., Gabrilove, J., Jackson, R., Sweeney, C., & Toto, R. (2015). Sustaining the Clinical and Translational Research Workforce: Training and Empowering the Next Generation of Investigators. 861-5. https://doi.org/10.1097/acm.0000000000000758
Fair, A M, et al. "Sustaining the Clinical and Translational Research Workforce: Training and Empowering the Next Generation of Investigators." vol. (2015): 861-5. doi: https://doi.org/10.1097/acm.0000000000000758
Fair AM, Yin HL, Gabrilove J, Jackson R, Sweeney C, Toto R. Sustaining the Clinical and Translational Research Workforce: Training and Empowering the Next Generation of Investigators. 2015;861-5. doi: 10.1097/acm.0000000000000758. UIID-AD: 3560.
Copy Download .nbib Format: NLM
Approaches to preparing young scholars for careers in interdisciplinary team science.

Begg MD, Martina CA, Crumley G, Fair AM, McCormack WT, Merchant C, Patino-Sutton CM, Umans JG.
UIID-AD: 2656
2014;62:14-25. doi: 10.231/jim.0000000000000021.

To succeed as a biomedical researcher, the ability to flourish in interdisciplinary teams of scientists is becoming ever more important. Institutions supported by the Clinical and Translational Science Awards (CTSAs) from the National Institutes of Health have a specific...

Cite
Begg MD, Martina CA, Crumley G, et al. Approaches to preparing young scholars for careers in interdisciplinary team science. 2014;62:14-25doi: 10.231/jim.0000000000000021.
Begg, M. D., Martina, C. A., Crumley, G., Fair, A. M., McCormack, W. T., Merchant, C., Patino-Sutton, C. M., & Umans, J. G. (2014). Approaches to preparing young scholars for careers in interdisciplinary team science. 6214-25. https://doi.org/10.231/jim.0000000000000021
Begg, M D, et al. "Approaches to preparing young scholars for careers in interdisciplinary team science." vol. 62 (2014): 14-25. doi: https://doi.org/10.231/jim.0000000000000021
Begg MD, Martina CA, Crumley G, Fair AM, McCormack WT, Merchant C, Patino-Sutton CM, Umans JG. Approaches to preparing young scholars for careers in interdisciplinary team science. 2014;62:14-25. doi: 10.231/jim.0000000000000021. UIID-AD: 2656.
Copy Download .nbib Format: NLM
Showing 121 to 128 of 128 entries